Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
Abercrombie & Fitch
(ANF - Get Report)
upgraded at Wells from Market Perform to Outperform, Wells Fargos said. International growth should accelerate and boost margins.
(CAH - Get Report)
upgraded at Argus from Hold to Buy, Argus Research said. $52 price target. Company is improving key operating metrics.
upgraded at RBC from Sector Perform to Outperform, RBC Capital said. Estimates also boosted, as business trends are improving. $68 price target.
(CLX - Get Report)
downgraded at UBS from Buy to Neutral, UBS said. Valuation call, based on a $72 price target.
rated new Buy at Goldman Sachs. $17 price target. Company is leveraged to food inflation.
downgraded at Credit Suisse to Neutral from Outperform on near term uncertainty, Credit Suisse said. Price target sunk to $23.
(EXPR - Get Report)
downgraded at Goldman from Buy to Neutral. $20 price target. Stock is already pricing in further margin expansion.
downgraded at Benchmark to Hold, Benchmark Capital said. Valuation call, ahead of the company's earnings report.
downgraded at Piper to Underweight, Piper Jaffray said. Earnings could peak this year.
upgraded at Baird from Neutral to Outperform, Robert Baird said. $27 price target. Company is leveraged to a demand recovery in cranes and foodservice equipment.
(NOK - Get Report)
downgraded at JP Morgan from Overweight to Underweight, JP Morgan said. $7 price target. Company is facing a multi-year transition.
(NOK - Get Report)
downgraded at Cowen to Underperform. Company has missed the opportunity in the tablet market and faces a long product transition with MSFT.
(NOR - Get Report)
rated new Hold at Citigroup. Valuation call, based on a $19 price target.
rated new Buy at Needham & Company. $24 price target. Sales visibility is improving.
upgraded at BB&T Capital to Buy. $39 price target. Railcar demand should continue to improve.
(WMT - Get Report)
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Company lacks near-term catalysts. $54 price target.